Inhibition of Inducible Nitric Oxide Synthase (iNOS) by Andrographolide and <i>In Vitro</i> Evaluation of Its Antiproliferative and Proapoptotic Effects on Cervical Cancer

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left">Molecular weight (g/mol)</td><td class="align_center">XLogP3</td><td class="align_center">Hydrogen bond acceptor count</td><td class="align_center">Hydrogen bond donor count</td><td class="align_center">Index of refraction</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left">350.4</td><td class="align_center">2.2</td><td class="align_center">5</td><td class="align_center">3</td><td class="align_center">1.568</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Drug-like properties of andrographolide.</div>

Oxidative Medicine and Cellular Longevity

tab4

Table 4

Table 4: Inhibition of Inducible Nitric Oxide Synthase (iNOS) by Andrographolide and <i>In Vitro</i> Evaluation of Its Antiproliferative and Proapoptotic Effects on Cervical Cancer 

Table 4 | Inhibition of Inducible Nitric Oxide Synthase (iNOS) by Andrographolide and In Vitro Evaluation of Its Antiproliferative and Proapoptotic Effects on Cervical Cancer 